Source: Zacks

MSN Laboratories: Exelixis Gets Favorable Ruling in Patent Litigation With MSN

The Delaware District Court ruled in EXEL's favor, rejecting MSN's challenge to three patents related to cabozantinib.

Read full article »
MSN Laboratories's Competitors | MSN Laboratories's News | MSN Laboratories's Financials
Stay up-to-date with the latest news on MSN Laboratories
Est. Annual Revenue
$500M-1.0B
Est. Employees
5.0-10K
MSN Reddy's photo - Managing Director of MSN Laboratories

Managing Director

MSN Reddy

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on MSN Laboratories